RUNX2 and thyroid tumor: In this work, we show for the first time that CDH6 is a novel TGF-β target gene in thyroid cells, and we demonstrate that its expression is controlled by RUNX2, which we have recently shown to be an important mediator of aggressive phenotype in thyroid tumor cells (Figure 7) [31].